| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9170190 | Journal of Cardiac Failure | 2005 | 7 Pages |
Abstract
Results of this study failed to confirm a reported survival benefit among HF patients carrying the AMPD1 T-allele. However, further studies in larger, more homogeneous populations should explore the possibility of a modest survival advantage for patients with ischemic HF.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Matthew J. BS, John F. PhD, Surai MS, Laura C. PhD, Bryant M. BA, Benjamin D. PhD, MPH, Joseph B. MD, Philip PhD, Jeffrey L. MD,